Published in Biochemistry on December 01, 2007
Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28
Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27
Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta (2011) 1.25
Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J Biol Chem (2009) 1.23
Intracellular localization and conformational state of transglutaminase 2: implications for cell death. PLoS One (2009) 1.07
A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. J Biol Chem (2011) 0.99
Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation. PLoS One (2011) 0.94
Regulation of the activities of the mammalian transglutaminase family of enzymes. Protein Sci (2012) 0.93
A mechanism for the upregulation of EGF receptor levels in glioblastomas. Cell Rep (2013) 0.90
The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase. Int J Clin Exp Med (2008) 0.88
Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization. Biochim Biophys Acta (2012) 0.88
Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptors. Proc Natl Acad Sci U S A (2014) 0.80
Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol (2014) 0.78
The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability. J Biol Chem (2016) 0.75
Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res (2013) 0.75
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41
Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05
Transglutaminases. Annu Rev Biochem (1980) 3.47
Transglutaminases: nature's biological glues. Biochem J (2002) 3.42
Caspase-independent cell death. Nat Med (2005) 3.42
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med (2002) 2.31
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A (2002) 2.15
Gene disruption of tissue transglutaminase. Mol Cell Biol (2001) 2.15
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol (2005) 2.00
Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci (2002) 1.92
Targeted inactivation of Gh/tissue transglutaminase II. J Biol Chem (2001) 1.86
COX-2-dependent cardiac failure in Gh/tTG transgenic mice. Circ Res (2003) 1.72
Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem (1987) 1.58
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell Death Differ (2002) 1.49
Transglutaminase 2 in the balance of cell death and survival. FEBS Lett (2005) 1.44
Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J Biol Chem (1999) 1.44
Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A (2003) 1.40
Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem (2004) 1.39
Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc Natl Acad Sci U S A (1999) 1.37
Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol Cell (1998) 1.30
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene (2006) 1.25
Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res (1997) 1.24
Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells. Neuroscience (2001) 1.23
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem (2002) 1.22
Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc Natl Acad Sci U S A (2006) 1.20
Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem (2006) 1.20
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol Cancer Ther (2005) 1.20
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia (2003) 1.19
Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol (2000) 1.14
Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem (1996) 1.11
GTP hydrolysis by guinea pig liver transglutaminase. Biochem Biophys Res Commun (1989) 1.11
Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J Biol Chem (2003) 1.11
Tissue transglutaminase is increased in Huntington's disease brain. J Neurochem (1999) 1.10
Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner. J Neurochem (2002) 1.10
Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death. J Biol Chem (2003) 1.08
The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol (1991) 1.08
Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J Biol Chem (1999) 1.07
GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket. J Biol Chem (2000) 1.06
Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem Int (2002) 1.06
Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem (1998) 1.04
Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem (2001) 1.03
Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis. Biochemistry (2006) 1.02
Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells. FASEB J (2007) 1.01
Transglutaminase II: a new class of GTP-binding protein with new biological functions. Cell Signal (1997) 1.00
Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh. J Biol Chem (1999) 1.00
Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity. J Biol Chem (1996) 0.99
Expression of GTP-dependent and GTP-independent tissue-type transglutaminase in cytokine-treated rat brain astrocytes. J Biol Chem (1997) 0.98
Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem (1988) 0.98
PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J Cell Biol (2003) 0.97
A continuous spectrophotometric linked enzyme assay for transglutaminase activity. Anal Biochem (1999) 0.94
Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei. Biochemistry (1995) 0.94
Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. J Neurochem (2002) 0.91
A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue. J Biol Chem (1992) 0.91
Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector. Biochem J (1998) 0.82
GTP hydrolysis by human tissue transglutaminase homologue. Biochem Biophys Res Commun (1996) 0.78
Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell (2010) 5.02
Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science (2011) 4.16
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A (2002) 2.15
Cool-1 functions as an essential regulatory node for EGF receptor- and Src-mediated cell growth. Nat Cell Biol (2006) 2.04
Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci U S A (2011) 2.01
Structural basis of m7GpppG binding to the nuclear cap-binding protein complex. Nat Struct Biol (2002) 1.61
Activated Cdc42 sequesters c-Cbl and prevents EGF receptor degradation. Cell (2003) 1.61
Structural elements, mechanism, and evolutionary convergence of Rho protein-guanine nucleotide exchange factor complexes. Biochemistry (2004) 1.55
Signaling to the Rho GTPases: networking with the DH domain. FEBS Lett (2002) 1.50
Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc Natl Acad Sci U S A (2008) 1.48
The Cool-2/alpha-Pix protein mediates a Cdc42-Rac signaling cascade. Curr Biol (2005) 1.41
Structure of the active N-terminal domain of Ezrin. Conformational and mobility changes identify keystone interactions. J Biol Chem (2002) 1.41
Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells. J Biol Chem (2004) 1.39
The molecular basis for the regulation of the cap-binding complex by the importins. Nat Struct Mol Biol (2009) 1.38
Regulation of the Cool/Pix proteins: key binding partners of the Cdc42/Rac targets, the p21-activated kinases. J Biol Chem (2001) 1.35
Epidermal growth factor-dependent regulation of Cdc42 is mediated by the Src tyrosine kinase. J Biol Chem (2003) 1.28
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med (2010) 1.27
New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes. J Biol Chem (2009) 1.27
Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. Mol Cancer Ther (2012) 1.27
Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget (2010) 1.24
Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion. J Biol Chem (2009) 1.23
The Cdc42 target ACK2 interacts with sorting nexin 9 (SH3PX1) to regulate epidermal growth factor receptor degradation. J Biol Chem (2002) 1.23
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. J Biol Chem (2002) 1.22
Two isoforms of tissue transglutaminase mediate opposing cellular fates. Proc Natl Acad Sci U S A (2006) 1.20
Cdc42 and Ras cooperate to mediate cellular transformation by intersectin-L. J Biol Chem (2005) 1.18
RhoGDI is required for Cdc42-mediated cellular transformation. Curr Biol (2003) 1.17
Novel regulatory mechanisms for the Dbl family guanine nucleotide exchange factor Cool-2/alpha-Pix. EMBO J (2004) 1.17
Establishment of a robust single axis of cell polarity by coupling multiple positive feedback loops. Nat Commun (2013) 1.13
Therapeutic strategies impacting cancer cell glutamine metabolism. Future Med Chem (2013) 1.12
Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells. J Biol Chem (2003) 1.11
Identification of a DOCK180-related guanine nucleotide exchange factor that is capable of mediating a positive feedback activation of Cdc42. J Biol Chem (2006) 1.09
Iqg1p links spatial and secretion landmarks to polarity and cytokinesis. J Cell Biol (2002) 1.06
Conserved structural motifs in intracellular trafficking pathways: structure of the gammaCOP appendage domain. Mol Cell (2003) 1.06
Microvesicles as mediators of intercellular communication in cancer. Methods Mol Biol (2014) 1.06
EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proc Natl Acad Sci U S A (2010) 1.05
Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42. J Biol Chem (2008) 1.02
Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis. Biochemistry (2006) 1.02
Rho GTPases and their roles in cancer metabolism. Trends Mol Med (2012) 1.01
Perturbing the linker regions of the alpha-subunit of transducin: a new class of constitutively active GTP-binding proteins. J Biol Chem (2004) 1.00
A unique role for heat shock protein 70 and its binding partner tissue transglutaminase in cancer cell migration. J Biol Chem (2011) 0.99
Cdc42-mTOR signaling pathway controls Hes5 and Pax6 expression in retinoic acid-dependent neural differentiation. J Biol Chem (2008) 0.98
Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation. J Biol Chem (2009) 0.97
Phosphorylation of the cool-1/beta-Pix protein serves as a regulatory signal for the migration and invasive activity of Src-transformed cells. J Biol Chem (2010) 0.95
A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor. J Biol Chem (2005) 0.92
The bicyclic intermediate structure provides insights into the desuccinylation mechanism of human sirtuin 5 (SIRT5). J Biol Chem (2012) 0.92
Antiapoptotic Cdc42 mutants are potent activators of cellular transformation. Biochemistry (2002) 0.92
New insights into the role of conserved, essential residues in the GTP binding/GTP hydrolytic cycle of large G proteins. J Biol Chem (2006) 0.92
Influencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42. Biochemistry (2006) 0.91
A mechanism for the upregulation of EGF receptor levels in glioblastomas. Cell Rep (2013) 0.90
Small angle X-ray scattering studies of mitochondrial glutaminase C reveal extended flexible regions, and link oligomeric state with enzyme activity. PLoS One (2013) 0.90
Understanding the catalytic mechanism of GTPase-activating proteins: demonstration of the importance of switch domain stabilization in the stimulation of GTP hydrolysis. Biochemistry (2002) 0.89
A link between Cdc42 and syntaxin is involved in mastoparan-stimulated insulin release. Biochemistry (2002) 0.89
Unloading RNAs in the cytoplasm: an "importin" task. Nucleus (2009) 0.88
Microfluidic isolation of cancer-cell-derived microvesicles from hetergeneous extracellular shed vesicle populations. Biomed Microdevices (2014) 0.88
The Cbl proteins are binding partners for the Cool/Pix family of p21-activated kinase-binding proteins. FEBS Lett (2003) 0.87
Deletion of Cdc42 enhances ADAM17-mediated vascular endothelial growth factor receptor 2 shedding and impairs vascular endothelial cell survival and vasculogenesis. Mol Cell Biol (2013) 0.87
R(h)oads to microvesicles. Small GTPases (2012) 0.86
Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation. J Neurosci (2012) 0.86
Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase. J Biol Chem (2002) 0.85
Prenylation and membrane localization of Cdc42 are essential for activation by DOCK7. Biochemistry (2013) 0.84
The adaptor protein and Arf GTPase-activating protein Cat-1/Git-1 is required for cellular transformation. J Biol Chem (2012) 0.84
Cancerous epithelial cell lines shed extracellular vesicles with a bimodal size distribution that is sensitive to glutamine inhibition. Phys Biol (2014) 0.83
Crystallization and preliminary crystallographic analysis of the ezrin FERM domain. Acta Crystallogr D Biol Crystallogr (2002) 0.83
A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival. J Biol Chem (2014) 0.83
C-terminal di-arginine motif of Cdc42 protein is essential for binding to phosphatidylinositol 4,5-bisphosphate-containing membranes and inducing cellular transformation. J Biol Chem (2012) 0.82
Inactivation of Cdc42 in embryonic brain results in hydrocephalus with ependymal cell defects in mice. Protein Cell (2012) 0.82
Effects of tissue transglutaminase on beta -amyloid1-42-induced apoptosis. Protein J (2006) 0.81
Interaction of activated Cdc42-associated tyrosine kinase ACK2 with HSP90. Biochem J (2004) 0.81
Tissue transglutaminase and its role in human cancer progression. Adv Enzymol Relat Areas Mol Biol (2011) 0.81
Ras and the FAK paradox. Mol Cell (2009) 0.81
A minimal Rac activation domain in the unconventional guanine nucleotide exchange factor Dock180. Biochemistry (2011) 0.81
A Cdc42 mutant specifically activated by intersectin. Biochemistry (2005) 0.80
Mutations in the polybasic juxtamembrane sequence of both plasma membrane- and endoplasmic reticulum-localized epidermal growth factor receptors confer ligand-independent cell transformation. J Biol Chem (2013) 0.80
Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention. Mol Pharm (2014) 0.80
Stabilization of an intermediate activation state for transducin by a fluorescent GTP analogue. Biochemistry (2004) 0.79
Mutational analysis of betaCOP (Sec26p) identifies an appendage domain critical for function. BMC Cell Biol (2008) 0.79
A dominant-negative Galpha mutant that traps a stable rhodopsin-Galpha-GTP-betagamma complex. J Biol Chem (2011) 0.79
Insulin-like growth factor-I diminishes the activation status and expression of the small GTPase Cdc42 in articular chondrocytes. J Orthop Res (2004) 0.79
X-ray crystal structures reveal two activated states for RhoC. Biochemistry (2007) 0.79
Biochemical characterization of the Cool (Cloned-out-of-Library)/Pix (Pak-interactive exchange factor) proteins. Methods Enzymol (2006) 0.78
Characterization of a novel activated Ran GTPase mutant and its ability to induce cellular transformation. J Biol Chem (2012) 0.78
Measurement of epidermal growth factor receptor turnover and effects of Cdc42. Methods Enzymol (2006) 0.78